Jiaping Li

12PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 06, 2025
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.

Haikuan Liu, Wenzhe Fan, Haiqing Li

|Jul 06, 2024
DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis.

Wenzhe Fan, Xinlin Zheng, Xiao Zhao

|Jun 26, 2023
Identification of BRD7 by whole-exome sequencing as a predictor for intermediate-stage hepatocellular carcinoma in patients undergoing TACE.

Kun Huang, Yanqin Wu, Wenzhe Fan

|May 24, 2023
A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma.

Chunhui Zhou, Yan Li, Jiaping Li

|Dec 23, 2022
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study.

Wenzhe Fan, Bowen Zhu, Shufan Yue

|Aug 03, 2022
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).

Zhenwei Peng, Wenzhe Fan, Bowen Zhu

Pageof 2

Frequent Collaborators

3 joint publications

Bowen Zhu

2 joint publications

Yiyang Tang

2 joint publications

Wenzhe Fan

1 joint publications

Yuanqing Zhang